Dec 08, 2023 / 03:00PM GMT
Operator
Good morning and welcome to the Codexis ECO Synthesis virtual KOL event. (Operator Instructions) As a reminder, this call is being recorded and a replay will be made available on the Codexis website following the conclusion of the event on today's call, are Dr. Stephen Dilly, Codexis President and Chief Executive Officer; Kevin Norrett, Codexis Chief Operating Officer; Stefan Lutz, Codexis SVP of Research as well as guest; Dr. John Maraganore; and Dr. David Butler.
During this call, management will be making a number of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding our projected cash runway to fund planned operations and our expectations for the supply and demand trajectories forward oligonucleotide therapeutics, evolving oligonucleotide manufacturing landscape, the potential for fully and dramatic colleague, oligonucleotide manufacturing technologies to improvements in patient outcomes and sustainability metrics. The anticipated improvements in speed, product, purity, yield, and energy efficiency of fully
Codexis Inc to Host Virtual KOL Event Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers